NCT06959017View on ClinicalTrials.gov

Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2025

Conditions

Hip Fracture of Intertrochanteric TypeThromboembolic EventOsteopeniaThrombosis Embolism

Interventions

GENETIC

Gene Expression Analysis

Each subject analysed for SERPİNH1 and ROCK1 gene exppression

Trial Locations (1)

34384

Prof Dr emil Tascıoglu City Hospital, Istanbul

All Listed Sponsors

collaborator

Sağlık Bilimleri University

UNKNOWN

lead

Saglik Bilimleri Universitesi

OTHER

NCT06959017 - Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis | Biotech Hunter | Biotech Hunter